Categories: Press-Releases

Kauvery Hospital Successfully Performs Leadless Pacemaker Implantation on a 58-year-old man, First in Trichy

[ad_1]


Kauvery Hospital Heart city – Trichy, a unit of Kauvery Group of Hospitals, a leading multispecialty healthcare chain in Tamil Nadu, today announced the successful implantation of a leadless pacemaker on a patient with recurrent pacemaker allergy.


 




Dr. T. Joseph, Lead Electrophysiology & Interventional cardiologist successfully performs Leadless Pacemaker Implantation on a 58-year-old man at Kauvery Hospital Heart city – Trichy


 


The patient, aged 58 years, had approached the hospital with complaints of multiple episodes of pacemaker erosion ever since he received an implant of a conventional (lead) artificial pacemaker in 2017 from another hospital. The patient’s case history was thoroughly studied by the medical experts lead by Dr. Joseph who then decided to go ahead with the implantation of a Leadless Pacemaker.


 


Speaking on the case, Dr. T. Joseph, Interventional Cardiologist and Lead Electrophysiologist, Kauvery Heartcity, Trichy, said, “The patient had previously been implanted with a conventional lead pacemaker 4-5 times on both left and right side of the chest at a hospital elsewhere, which kept getting eroded. My team and I explained to the patient the advantages of a leadless pacemaker – AV MICRA (Dual chamber), which is an advanced device and non-allergic to patients. The patient agreed to go ahead with the implantation.”


 


Pacemaker allergy is a rare phenomenon that can present with a spectrum of mild local inflammation to severe systemic inflammation and hence remain a serious concern to the affected heart patients. This results in multiple device replacements, high cost to patient and increased morbidity burden.


 


“Leadless pacemakers are introduced in Cardiac Electrophysiology with the goal to avoid lead and pocket-associated complications from conventional artificial pacemakers (CPM). The leadless pacemaker is 90% smaller than a conventional/transvenous pacemaker. The device weighs less than 9 gms and has a volume of 0.8cc. It is a miniature device sent directly to the heart through a catheter. It is a self-contained generator, where the electrode system (battery) is directly implanted into the right ventricle. The device is implanted via a femoral vein transcatheter approach; it requires no chest incision or subcutaneous generator pocket whereas, in a conventional pacemaker, the electrode system is placed in the pectoral area (chest) with wires connected to the heart. This technology turned out to be the best option for this particular patient,”

 added Dr. T. Joseph.


 


Commenting on the success of the case, Dr. T. Senthil Kumar, Executive Director and Chief Cardio Thoracic-Vascular Surgeon, Kauvery HeartCity, Trichy said, “This technology is relatively new in the market, having been introduced in 2018 and has been offered to only 8-9 cases in our country. This is the first time in Trichy, and 2nd in Tamilnadu, that this type of advanced Leadless chip Pacemaker AV MICRA, with Dual chamber, has been used on patients.


 


Dr. Joseph has used the same technology for a 7-year old child in 2020, which was the first in the country, and globally the 3rd paediatric Implant. This placed India on a world pedestal, at a Pacing Series Workshop in 2020 held in Hungary.


 


Allergic reactions to pacemaker device components are uncommon. However, when they occur, they usually mimic pacemaker infection, which results in multiple pacemaker replacements. This is what happened to the adult patient featured here. He approached us and we were able to provide him the better procedure that shall ensure that his woes won’t return, and that he shall not be troubled with further complications in the future. Without the right treatment from the right specialists, these infections can be life-threatening – making it crucial to seek and find the highest level of care as soon as possible.”


 


The patient was discharged post-observation the very next day after the implantation. He will however be visiting the hospital to get the device monitored over the coming months.

[ad_2]

Source link

NewsVoir

Recent Posts

Share repurchase programme

[ad_1] Nørresundby, 26 April 2024Announcement no. 23/2024 The Board of Directors of RTX has, cf. company announcement no. 20/2023 dated…

5 days ago

Gyroscope Market Size, Share And Growth Analysis For 2024-2033

[ad_1] Gyroscope Global Market Report 2024 – Market Size, Trends, And Global Forecast 2024-2033 The Business Research Company's Gyroscope Global…

5 days ago

Casting Off the Caste System and its Stigma: Empowering the Forgotten Indigenous People of India with Human Rights

[ad_1] ODISHA, India, and LOS ANGELES, Calif., April 25, 2024 (SEND2PRESS NEWSWIRE) — In the 1880s, to call attention to…

5 days ago

Alipay+ Enables Digital Payment of 14 Overseas E-wallets from 9 Countries and Regions in Hong Kong to Support City’s Global Travel Drive

In support of Hong Kong's new mega tourism and commerce drive, Alipay+ now enables users of 14 leading overseas mobile…

5 days ago

Celebrate "Bleach: Brave Souls" Reaching Over 90 Million Downloads Worldwide with "The Future Society Zenith Summons: Cyber" Featuring New Versions of Ulquiorra, Orihime, and Nnoitora

[ad_2] TOKYO, April 26, 2024 /PRNewswire/ -- KLab Inc. announced that its hit 3D action game Bleach: Brave Souls has…

5 days ago

TransAlta Declares Dividends

[ad_1] CALGARY, Alberta, April 24, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of TransAlta Corporation (TSX: TA) (NYSE: TAC)…

6 days ago